Upcoming MC Radio Shows—January 28, 2022
Join us for one of our favorite shows of the year as Dr. Robert Orlowski to help us know what we have to look forward to in 2022 in multiple myeloma advances. Join us Monday, 2/7 @ 2 pm Central!
Upcoming MC Radio Shows—October 21, 2020
Oct 23 @ 2 pm Eastern - How venetoclax is being used as the first precision therapy medicine for t(11;14) myeloma patients with Jonathan Kaufman, MD Emory University
Upcoming MC Radio Shows—May 18, 2020
Antibody testing is quickly evolving for COVID-19. Learn how Dr. Russell's company is developing a new test to detect neutralizing-only antibodies.
Upcoming MC Radio Shows—September 20, 2019
Learn more about a completely new approach for myeloma care delivering a radiosensitive treatment directly to myeloma cells. Monday, 9/23 @ 10 am Central.
Upcoming MC Radio Shows—August 30, 2019
Myeloma researchers are running the largest myeloma screening study in the world with over 50,000 patients and family members. Learn more 9/4 at 1 pm EST.
Upcoming MC Radio Shows—October 21, 2016
Join us for a myeloma clinical trials 101 explanation by Memorial Sloan Kettering's Dr. Nikoletta Lendvai as well as a review of the new drug, selinexor.
Upcoming MC Radio Shows—October 15, 2016
How can patients position themselves to find their best options at myeloma relapse? Whether it's an early or late relapse, this expert has suggestions.
Upcoming MC Radio Shows—September 26, 2016
Now that daratumumab is being used in the clinic, what have researchers learned about its use? Hear from myeloma expert, Dr. Torben Plesner from Denmark.
Upcoming MC Radio Shows—August 28, 2016
What does 40 years of data teach us about early myeloma conditions MGUS and smoldering myeloma? Learn from the pioneer and expert who defined the terms.
Upcoming MC Radio Shows—April 12, 2016
Myeloma is a wiley blood cancer and most patients will relapse. Which new combinations are best for relapsed or refractory myeloma patients?
Copyright © 2021 HealthTree Foundation. All Rights Reserved.
The HealthTree Foundation / Myeloma Crowd is a qualified 501(c)(3) tax-exempt organization. Tax ID 45-5354811